Immunosuppression for lung transplantation: evidence to date.

  title={Immunosuppression for lung transplantation: evidence to date.},
  author={Gregory Ian Snell and Glen Philip Westall},
  volume={67 11},
With the introduction of ciclosporin (cyclosporine) into routine clinical practice 20 years ago, lung transplantation has become an established treatment for patients with advanced lung disease. Most lung transplant recipients routinely continue to receive a triple-drug maintenance immunosuppressive regimen consisting of a calcineurin inhibitor, an antimetabolite and corticosteroids. The use of antibody-based induction therapy remains common, although there has been a shift away from T cell… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 23 extracted citations

Immunosuppression: what's standard and what's new?

Seminars in respiratory and critical care medicine • 2013

Similar Papers

Loading similar papers…